Staphylococcus aureus can use an alternative pathway to be internalized by osteoblasts in absence of β1 integrins Authors: Léo-Paul Tricou, William Mouton, Andréa Cara, Sophie Trouillet-Assant, Daniel Bouvard, Frédéric Laurent, Alan Diot, Jérôme Josse Published: 2024 ABSTRACT AbstractStaphylococcus aureus main internalization mechanism in osteoblasts relies on a tripartite interaction between bacterial fibronectin-binding proteins, extracellular matrix soluble fibronectin, and osteoblasts’ β1 integrins. Caveolins, and particularly caveolin-1, have been shown to limit the plasma membrane microdomain mobility, and consequently reduce the uptake of S. aureus in keratinocytes. In this study, we aimed to deepen our understanding of the molecular mechanisms underlying S. aureus internalization in osteoblasts. Mechanistically, S. aureus internalization requires endosomal recycling of β1 integrins as well as downstream effectors such as Src, Rac1, and PAK1. Surprisingly, in β1 integrin deficient osteoblasts, S. aureus internalization is restored when Caveolin-1 is absent and requires αvβ3/5 integrins as backup fibronectin receptors. Altogether, our data support that β1 integrins regulate the level of detergent-resistant membrane at the plasma membrane in a an endosomal and Caveolin-1 dependent manner.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-024-78754-z.Keywords: Staphylococcus aureus, Internalization, β1 integrin, Caveolin-1, Detergent-resistant membrane, OsteoblastsSubject terms: Cell biology, Mechanisms of disease, Membrane trafficking, Infectious diseases, Bacterial infection, Immune evasion, Bacterial infection, Infection, Cellular microbiology, Bacterial host response, Bacterial immune evasion, Cellular microbiology Introduction Integrins are the main class of receptors implicated in the interactions between cells and the extracellular matrix (ECM)1. Binding of integrins to ECM ligands can activate signaling pathways, including the FAK, Src, Rho GTPases (Rac1, CDC42 and RhoA), Erk and PI3-kinase pathways. This interaction influences cytoskeleton organization, which accounts for many of the integrin-regulated biological functions such as proliferation, apoptosis, cell fate decision, and extracellular matrix organization2. β1 integrins play important roles in the ECM/cell interactions, especially in bone and joint tissues. Direct interactions between osteoblasts, the bone forming cells, and the ECM, are mediated by a select group of integrin receptors that includes α5β1, α3β1 and α8β13,4. These integrins can interact with fibronectin, a glycoprotein that can be found in the ECM, but also as a soluble form in plasma5. It was reported that α5β1 integrin mediates critical interactions between osteoblasts and fibronectin, which are required for both bone morphogenesis and osteoblast differentiation3,6. Several studies showed that integrins are associated with detergent-resistant membranes (DRMs), specific membrane microdomains that are rich in cholesterol, sphingolipids, and other proteins7,8. DRMs play important roles in the regulation of cell adhesion to the ECM and associated cell migration, by concentrating molecules such as Src or Rac1 at the plasma membrane involved in the downstream signaling pathways of integrins8. Moreover, integrins including the β1 subtype, are known to be constitutively endocytosed and recycled. These processes are essential for cell migration, and to ensure the turnover of the ECM9,10. Clathrin is a molecular scaffold that can form a cage-like structure at the plasma membrane and that is involved in the classical endocytosis of cargo11. Interestingly, integrin endocytosis can be mediated through both clathrin-dependent and clathrin-independent mechanisms, and the same integrin heterodimer can use multiple pathways for its endocytosis. Indeed, while a clathrin-dependent mechanism for α5β1 integrin endocytosis has been described during cell migration or division12–14, a caveolin-dependent pathway is observed during fibronectin-α5β1 endocytosis15. Caveolae are cholesterol-enriched subtype of DRMs predominantly composed of Caveolin-1 (Cav1), which is the most abundant isotype within the caveolar structure16. Cav1 is also the key element of the caveolar endocytosis process, as it requires Cav1 phosphorylation on Tyr 14 to occur17. Furthermore, Rac-binding sites can be found in cholesterol-enriched domains and seem to be endocytosed by a caveolin-dependent pathway. Consequently, Cav1 is very likely to manage regulation of Rac-binding sites endocytosis16,18. However, this internalization is only possible in the presence of β1 integrins, as they play a major role in caveolae insertion stability into the plasma membrane19,20. On the other side of the plasma membrane, β1 integrins are also the key receptors in the integrin-mediated internalization of fibronectin-binding pathogens such as Staphylococcus aureus21. S. aureus is a commensal bacterium of the skin that can cause a wide range of infections such as pneumonia, bacteriemia, infective endocarditis but also bone and joint infections22. For many years, S. aureus has been considered as an extracellular pathogen but is now widely acknowledged to be a facultative intracellular organism. Its intracellular survival in neutrophils, monocytes, macrophages, and other professional phagocytic cells, has been first described in the 1950s23,24. Intracellular S. aureus is protected against both antibiotics and the host immune response, using the cell as a trojan horse25. However, S. aureus internalization by nonprofessional phagocytic cells (NPPCs) such as epithelial cells, endothelial cells, fibroblasts, or osteoblasts can also occur26–29, and is also a phenomenon found in other Staphylococcus species such as Staphylococcus pseudintermedius30 or Staphylococcus epidermidis31, suggesting its importance as a virulence factor in staphylococcal evolution. More importantly, several studies reported the presence of intracellular S. aureus inside NPPCs from clinical samples such as nasal mucosa samples or bone samples, suggesting that S. aureus presence inside host cells may contribute to its pathogenicity32,33. In vitro experiments revealed that S. aureus internalization in NPPCs is mainly achieved through a tripartite interaction between bacterial adhesins called fibronectin-binding proteins (FnBP), free soluble fibronectin in the extracellular medium and α5β1 integrin on the host NPPC surface34,35. S. aureus can express 1 or 2 FnBP isotypes (FnBPA and FnBPB), for which the deletion or an inactivation leads to a significant decrease of the internalization efficacy28,36. While β1 integrin downstream effectors such as Src and FAK are also involved in the NPPCs invasion pathway, it has been observed that S. aureus colocalizes with host membrane cholesterol, strongly suggesting that internalization happens in cholesterol-enriched microdomain such as DRMs37–40. Regarding the phagocytosis mechanism, Veiga et al. reported that S. aureus internalization in HeLa cells is clathrin-dependent41. Hoffman et al. showed that Cav1-deficient fibroblasts exhibited an increased uptake of S. aureus. They reported that this potentiated internalization may be related to an enhanced mobility of membrane microdomain-associated proteins when Cav1 is missing42. However, signaling pathways involved as well as the roles of Cav1 and DRMs are still not fully understood. In this study, we aim to deepen our understanding of molecular mechanisms required for S. aureus internalization by NPPCs. First, we validated the role of FnBPs, fibronectin and β1 integrin in our murine osteoblast model. We reported the role of Src, Rac1 and PAK1 (a downstream effector of Rac1 that regulates actin structure) in the internalization process. Then, we showed that the absence of Cav1 expression rescued the S. aureus internalization in β1-deficient osteoblasts. Finally, we reported that Cilengitide, an αv integrin inhibitor, significantly impaired S. aureus internalization in β1- and Cav1-deficient osteoblasts, suggesting that αvβ3/5 integrin may play the role of an alternative cell receptor for S. aureus internalization in absence of β1 integrin and Cav1. Materials and methods Staphylococcus aureus strains We used the S. aureus 8325-4 and its isogenic strain S. aureus DU5883, which is deficient for FnBPA and FnBPB, and therefore incapable to invade cells43,44. Cell lines and culture conditions Several murine pre-osteoblastic cell lines were used in this study (Table 1). OBβ1+/+ and OBβ1−/− were obtained as described by Brunner et al.6. OBβ1+/+ SrcY530F and OBβ1−/− SrcY530F were generated via retroviral infection using a vector expressing constitutive active form of Src, SrcY530F. Cav1 knock-out cells (OBβ1f/fCav1KO and OBβ1−/−Cav1KO) were generated by CRISPR-Cas9 technology. Three separate guide RNAs were used to target the mouse Caveolin1 gene (Santa Cruz Biotechnology, sc-419479). Plasmids expressing gRNA together with Cas9 and GFP were transiently transfected into SV-40 immortalized pre-osteoblast cell line (OBβ1+/+ and OBβ1−/−) as previously reported. Single cells were FACSorted based on GFP expression and growing clones were further characterized for the loss of caveolin1 expression by western-blot and immunofluorescence. Cells were cultured in 75 cm² flasks (T75, Corning Inc. BD Falcon, Corning, NY, USA) at 37 °C under 5% CO2, in a complete culture medium composed of DMEM (Dulbecco’s Modified Eagle Medium) containing pyruvate, D-glucose (1 g/L) and L-Glutamine (1 g/L) (Thermo Fischer Scientific Gibco 31885, Waltham, MA, USA) and supplemented again with L-glutamine (Gibco, 25030), 10% fetal calf serum (FCS, Gibco 10270), and with both penicillin (100 µg/mL) and streptomycin (100 µg/ml) (Gibco 15140). Table 1Murine pre-osteoblastic cell line used in this study.NameCharacteristicsReferenceOBβ1+/+WildtypeBrunner et al., 20116OBβ1−/−Absence of β1 integrin expressionBrunner et al., 20116OBβ1+/+SrcY530FConstitutive activation of SrcThis studyOBβ1−/− SrcY530FAbsence of β1 integrin expression and constitutive activation of SrcThis studyOBβ1+/+Cav1KOAbsence of Cav1 expressionThis studyOBβ1−/− Cav1KOAbsence of β1 integrin and Cav1 expressionThis study Murine pre-osteoblastic cell line used in this study. Infection and lysostaphin protection assay 50,000 cells per well were seeded in a 24-well plate (Corning Inc. BD Falcon, Corning, NY, USA) and incubated for 48 h to allow confluency, before being infected at a MOI of 1:1 with the previously indicated strains. After 2 h of contact, 10 µg/mL lysostaphin (Sigma-Aldrich, Burlington, MA, USA) were added for 1 h to eliminate adherent and non-adherent extracellular bacteria. Bacterial internalization was then assessed after osmotic shock-induced cell lysis and plating of lysates on TSA agar plates (BioMérieux, Marcy-l’Étoile, France) using the Easy Spiral automaton. (Interscience, Roubaix, France). Colony Forming Units (CFU) were counted after 18 to 24 h of incubation at 37 °C. Antibodies and chemical inhibitors Several chemical inhibitors were used in these experiments and are listed in Table 2. All inhibitors were diluted in culture medium without antibiotics. The cells were pretreated for 1 h before infection and during the 2 h-long contact with bacteria. Cell infection was carried out as described in the above paragraph. Of note, none of the antibodies and chemical inhibitors showed any signs of cytotoxicity at the used concentrations. Table 2Chemical inhibitors used in this study.Inhibitor / AntibodiesTargetUsed concentrationSupplierSrc Inhibitor No.5Src10 µMProteinKinase (Kassel, Germany)EHT 1864Rac15 µMSigma-Aldrich (Burlington, MA, USA)p21-Activated Kinase Inhibitor III, IPA-3Pak15 µMPrimaquineendosomal trafficking5 µMCilengitideαv integrin0.5 µManti-CD29 antibodiesintegrin β1 (CD29)10 µg/mlBD Pharmingen (Franklin Lakes, MA, USA)anti-fibronectin antibodiesfibronectin10 µg/mlBD Transduction (Franklin Lakes, MA, USA) Chemical inhibitors used in this study. Detergent resistant membranes distribution assessment by flow cytometry DRMs distribution on the cell surface was assessed by staining the cells with cholera-toxin coupled to FITC (CT-FITC, Sigma-Aldrich, Burlington, MA, USA). The target of cholera toxin is GM1 (monosialotetrahexosylganglioside), a sphingolipid used as a marker of DRMs. Trypsinized cells (100,000) were washed once with ice-cold PBS (500 ml-5 min-4 °C) and stained with 1 µg/mL of CT-FITC for 30 min at 4 °C. The cells were then washed twice with ice-cold PBS and fixed at 4 °C with 3.7% paraformaldehyde (PFA, Sigma-Aldrich, Burlington, MA, USA) for 10 min. The fixed cells were then washed once in ice-cold PBS and stored in 1 mL PBS at 4 °C in the dark until analysis on a BD Accuri™ C6 (FL1-H). Graphical representation and statistical analysis Results were presented as number of intracellular CFU for 50 000 cells, except for Figs. 2d and 3b where results were presented as percentage of CT-FITC staining compared to OBβ1+/+ cells. Data is presented as boxplots (1st quartile, median, 3rd quartile) with whiskers indicating minimal and maximal values. All value points (technical replicates and biological replicates) are also presented for each condition. Due to the number of values, non-parametric Mann-Whitney tests were performed on all value points (technical replicates and biological replicates) when applicable. All analysis were performed using GraphPad Prism 9 Software (GraphPad Software Inc., Boston, MA, USA). Results Validation of the “FnBPs-fibronectin-β1 integrin” internalization pathway in OBβ1 cells To validate the role of the β1 integrin in the cellular internalization of S. aureus, we used the OBβ1 murine pre-osteoblasts cell line expressing (OBβ1+/+) or not expressing (OBβ1−/−) β1 integrin6 and the S. aureus strains expressing (8325-4) or not expressing (DU5883) FnBPs in a lysostaphin protection assay. In absence of β1 integrin, internalization of the 8325-4 strain into osteoblasts was significantly decreased by 3 Log, from 2.2 × 103 to 0 intracellular CFU per 50,000 cells (Fig. 1a, median values, p < 0.0001). For the DU5883 strain, the internalization significantly dropped from 15,4 intracellular CFU per 50,000 cells to 0 in absence of β1 integrin (Fig. 1a, p = 0.0023). Regarding the FnBP-dependent internalization, the internalization of DU5883 was significantly decreased by 99% in OBβ1+/+ cells compared to the 8325-4 parental strain (Fig. 1a, p < 0.0001). These results correlate with our previous work on S. aureus internalization in the same osteoblast cell line44, and with the literature in other cell lines34,36,45. In OBβ1−/− cells, no significant difference was observed between 8325 and 4 and DU5883 strains, due to a negligeable number of internalized bacteria in both cell lines (Fig. 1a). The role of β1 integrin and fibronectin in the internalization process was also confirmed using anti β1 and anti-fibronectin blocking antibodies respectively (Fig. 1b, c). Internalization of Staphylococcus aureus 8325-4 inside OBβ1 osteoblasts is dependent of Fibronectin-binding proteins, fibronectin and β1 integrin. (a) Internalization of S. aureus 8325-4 and DU5883 (its isogenic counterpart deficient for FnBPs) inside OBβ1+/+ and OBβ1-/- (OBβ1 deleted for β1 integrin). 3 independent experiments in technical triplicates (3 wells for each condition for each experiment) were performed. Non-parametric Mann-Whitney tests were performed. ** or **** means p < 0.01 and p < 0.0001, respectively. NS means that no significative difference was observed. (b) Internalization of S. aureus 8325-4 inside OBβ1+/+ pretreated or not with anti-β1 integrin antibodies before the infection. (c) Internalization of S. aureus 8325-4 inside OBβ1+/+ pretreated or not with anti-fibronectin antibodies before the infection. Results were presented as number of intracellular colony-forming units (CFU) for 50 000 cells. As validation experiments, only one experiment in technical triplicate was performed for (b) and (c), so no statistical analysis was performed. Chemical inhibition of Src, Rac1, PAK1, and endosomal recycling impairs the internalization of S. aureus 8325-4 in OBβ1 cells The signaling protein Src has been shown to play a pivotal role in the internalization process of S. aureus in HeLa and 293T cells37,38. When treated with a chemical Src inhibitor, the internalization of 8325-4 was strongly impaired in OBβ1 cells (Fig. 2a, 2.6 × 103 vs. 1.5 × 102 intracellular CFU per 50,000 cells, median values, p < 0.0001). As former results have suggested that Src activity was triggered following the contact between S. aureus and β1 integrins38, we also investigated if Src activation could rescue the internalization of S. aureus in absence of β1 integrin, by expressing a constitutively active form of Src (SrcY530F) in a β1-deficient osteoblast cell line. Interestingly, we observed that constitutive activation of Src led to a 4-fold decrease in the internalization of 8325-4 strain, from 2.5 × 103 to 5.8 × 102 intracellular CFU for 50,000 cells (Fig. S1, median values, p = 0.0411). In OBβ1−/−SrcY530F, constitutive activation of Src was not able to rescue S. aureus internalization in absence of β1 integrin (Fig. S1). Internalization of Staphylococcus aureus 8325-4 inside OBβ1 osteoblasts is dependent of Src kinase, Rac1, PAK1 and endosomal recycling. (a) Internalization of S. aureus 8325-4 inside OBβ1+/+ pretreated or not with Src inhibitor before the infection. (b) Internalization of S. aureus 8325-4 inside OBβ1+/+ pretreated or not with Rac1 and PAK1 inhibitors prior to the infection. (c) Internalization of S. aureus 8325-4 inside OBβ1+/+ pretreated or not with primaquine before the infection. Results were presented as number of intracellular colony-forming units (CFU) for 50 000 cells. At least 3 independent experiments in technical triplicates (3 wells for each condition for each experiment) were performed. Non-parametric Mann-Whitney tests were performed. ** and **** means p < 0.01 and p < 0.0001, respectively. (d) Presence of GM1 (marker of DRMs) at the surface OBβ1+/+ pretreated with primaquine and OBβ1-/-. Results were presented as percentage of CT-FITC staining compared to the non-treated OBβ1+/+ cells. Three independent experiments but without technical duplicate or triplicate were performed for (d), so no statistical analysis was performed. Then we performed chemical inhibitions of Rac1 and PAK1 to investigate the impact on the internalization of S. aureus. These two proteins are downstream Src and are involved in several cell mechanisms, especially in cytoskeletal reorganization. We observed that inhibition of PAK1 reduced S. aureus internalization by 56% (Fig. 2b, 6.3 × 103 vs. 2.8 × 103 intracellular CFU per 50,000 cells in presence or absence of PAK1 inhibitor respectively, median values, p < 0.0001). In the same way, Rac1 inhibition also impaired S. aureus internalization, decreasing S. aureus internalization by 81% (Fig. 2b, 6.3 × 103 vs. 1.2 × 103 intracellular CFU per 50,000 cells, median values in presence or absence of Rac1 inhibitor respectively, p < 0.0001). Finally, we investigated the role of DRMs and endosomal recycling on the internalization of S. aureus, as β1 integrin and DRMs co-regulate their recycling at the plasma membrane46. After its endocytosis, integrin and DRMs can be recycled to the membrane. To do so, OBβ1+/+ cells were pretreated with primaquine, an anti-malaria drug that interferes with membrane recycling from endosomes to the plasma membrane through a direct interaction with them47. After primaquine treatment, S. aureus 8325-4 strain internalization was decreased by 72% (Fig. 2c, 6.3 × 103 vs. 1.8 × 103 intracellular CFU per 50,000 cells, median values, p < 0.0001). To support the impact of primaquine on endosomal recycling, we used our ability to stain DRMs (especially glycosphingolipid GM1) using cholera-toxin fused to FITC fluorescent protein (CT-FITC) to assess the integrity of the vesicular transport in our OBβ1+/+ and OBβ1−/− cell lines. Our results showed that primaquine treatment induced a 34% decreased of DRMs presence at the cell surface compared to non-treated cells (Fig. 2d). Interestingly, we also observed that β1 integrin deletion led to a 48% decrease of CT-FITC staining compared to the non-treated wildtype cells, supporting co-regulation of β1 integrin and DRM recycling (Fig. 2d). Overall, inhibiting the downstream effectors of integrin β1 or its putative relocation to cell membrane through endosomal recycling impacts the internalization of S. aureus. Moreover, it seems that β1 integrin might be involved in the control of the recycling endosome trafficking back to the plasma membrane. Altogether, these observations suggest that inhibition of β1 integrin or its supposed relocation to the plasma membrane via endosomal recycling appears to impair S. aureus internalization. Caveolin-1 deletion partially rescues the internalization in OBβ1−/− cells Caveolin-1 (Cav1) is a structural component of membrane compartments called caveolae that has been thought to be a negative regulator of the internalization pathway in fibroblasts expressing β1 integrin42. We decided to analyze how Cav1 modulates S. aureus internalization in OBβ1 cells, especially in absence of β1 integrin. Contrary to observations in fibroblasts42, we did not observe an increased bacterial internalization when the caveolin1 gene was invalidated in OBβ1+/+ cells (Fig. S2). Interestingly, while we observed 0 CFU for OBβ1−/− cells with functional Cav1, we noticed a significant rescue of S. aureus internalization with 3,4 × 102 intracellular CFU per 50,000 cells in Cav1-deficient OBβ1−/−, which accounts for 12% of S. aureus internalization in OBβ1+/+ cells (Fig. 3a, 3.4 × 102 vs. 2.8 × 103 intracellular CFU per 50,000 cells, median values, p = 0.022). GM1 and DRMs presence among these 3 cell types were then assessed using CT-FITC staining. A rescue of DRMs presence at the host cell surface was also observed as OBβ1−/−Cav1KO cells presented a 115% of CT-FITC staining similar to OBβ1+/+ cells, whereas staining in OBβ1−/− cells was decreased by 48% (Fig. 3b, median values). Absence of Cav1 in OBβ1−/− (OBβ1−/− Cav1KOosteoblasts) rescues the internalization of Staphylococcus aureus 8325-4. (a) Internalization of S. aureus 8325-4 inside OBβ1−/−Cav1KO and OBβ1−/−. Results were presented as number of intracellular colony-forming units (CFU) for 50 000 cells. Two independent experiments in technical triplicates (3 wells for each condition for each experiment) were performed. Non-parametric Mann-Whitney test was performed. ** means p < 0.01. (b) Presence of GM1 (marker of DRMs) at the surface of OBβ1−/−Cav1KO and OBβ1−/−. For (b), results were presented as percentage of CT-FITC staining compared to the control cells (OBβ1+/+). Three experiments but without technical duplicate or triplicate were performed, thus no statistical analysis was performed. Our results suggest that S. aureus could be internalized via an alternative pathway in absence of β1 integrin, which is potentially repressed by Cav1. Interestingly, Cav1 also impacts the endosomal recycling in OBβ1−/− cells. Internalization of S. aureus in absence of β1 integrin and Cav1 is FnBP-dependent and αvβ3/5-dependent To explore the internalization pathway in OBβ1−/−Cav1KO cells, we first performed internalization experiments using S. aureus strains with (8325-4) or without (DU5883) functional FnBPs. We observed that the internalization of DU5883 is decreased by 98% compared to 8325-4 in OBβ1−/−Cav1KO cells (Fig. 4a, 5.5 × 102 vs. 13 intracellular CFU per 50,000 cells, median values, p < 0.0001). This pattern is similar to the one observed for OBβ1+/+ cells, suggesting that FnBPs are involved (Fig. 4a, 7.6 × 103 vs. 83 intracellular CFU per 50,000 cells, median values, p < 0.0001). Then, we identified the host cell receptor that mimics the role of the α5β1 integrin when β1 integrin is missing. As the αvβ3 integrin was reported in S. epidermidis adhesion on osteoblasts, we hypothesized that it could be an adequate host cell receptor48. For this purpose, we utilized Cilengitide, a specific inhibitor of αvβ3 and αvβ5 integrins49. After treatment of OBβ1−/−Cav1KO cells with Cilengitide, the internalization of S. aureus 8325-5 was decreased by 90% (Fig. 4b, 1.38 × 102 vs. 13 intracellular CFU per 50,000 cells, median values, p < 0.0022). However, when OBβ1+/+ cells were treated with Cilengitide, no effect on the internalization of S. aureus was observed (Fig. 4b). Considering these results, it seems that αvβ3 (or αvβ5) integrin may be the major host receptor involved in internalization of S. aureus in OBβ1 cells, in absence of β1 integrin and Cav1. Considering the apparent similarities in bacterial and cell surface proteins involved in S. aureus internalization in both OBβ1+/+ and OBβ1−/−Cav1KO cell lines, we also explored the effect of chemical inhibition of intracellular integrin downstream effectors and endosomal recycling on S. aureus invasion in OBβ1−/−Cav1KO. Similar to our previous observations in OBβ1+/+ cells, we observed that internalization of S. aureus in OBβ1−/−Cav1KO cells was significantly decreased by chemical inhibition of Src, PAK1, Rac1, and the endosomal recycling (through primaquine treatment) by 100% after Src inhibition, 73% after PAK1 inhibition, 60% after Rac1 inhibition, and 82% after primaquine treatment (Fig. 4c, p < 0.0001, p = 0.026, p = 0.0206 and p = 0.0028 respectively). Internalization of Staphylococcus aureus 8325-4 inside OBβ1−/− Cav1KO cells is dependent on Fibronectin-binding proteins, αvβ3/5 integrin, Src kinase, Rac1, PAK1 and endosomal recycling. (a) Internalization of S. aureus 8325-4 and DU5883 inside OBβ1+/+ and OBβ1−/−Cav1KO. (b) Internalization of S. aureus 8325-4 inside OBβ1+/+ and OBβ1−/−Cav1KO pretreated or not with Cilengitide (a specific inhibitor of αv integrins) before the infection. (c) Internalization of S. aureus 8325-4 inside OBβ1+/+ and OBβ1−/− Cav1KO pretreated or not with Src, PAK1 and Rac1 inhibitors or primaquine before the infection. Results were presented as number of intracellular colony-forming units (CFU) for 50 000 cells. At least 2 independent experiments in technical triplicates (3 wells for each condition for each experiment) were performed. Non-parametric Mann-Whitney tests were performed with Prism GraphPad. *, **, *** or **** means p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively. NS means that no significative difference was observed. Discussion S. aureus infection often leads to difficult to treat bone and joint infections, mainly because of its ability to escape the immune response via internalization into osteoblasts. This internalization not only perturbs bone deposition balance by reducing osteoblast differentiation, and promoting bone degradation, but also constitutes a bacteria reservoir promoting chronicity33,44,50. In this study, we aimed to deepen our current understanding of the molecular mechanisms that control S. aureus internalization51. Although we confirmed previous data showing that S. aureus internalization into osteoblasts requires a functional β1 integrin/fibronectin/FnBP tripartite axis, our present work provides a novel and extended view on how β1 integrins are involved in this process. Indeed, we propose a new picture in which β1 integrins promote S. aureus internalization not only as cell surface receptor but also by driving GM1 relocation to the plasma membrane. GM1 is a lipid marker for the so-called detergent resistant rich membranes (DRM), involved in the formation of membranous subcellular domains that concentrate and stabilize signaling proteins such as Rac1, PAK1, and Src. Consequent to this local recruitment and activation of signaling proteins, numerous biological processes are triggered such as cell adhesion, migration, and internalization52. Our data fully supports previous data showing that β1 integrins are required for GM1 trafficking back to the plasma membrane20. Loss of cell adhesion to the ECM has been shown to promote DRM internalization likely via a Cav1 dependent route. Indeed, the low GM1 content associated with the absence of β1 integrins was partially restored back upon co-removal of Cav1. Thus, our data support this hypothesis, and demonstrate that β1 integrins, by promoting the trafficking back to and likely the stabilization of Cav1 at the plasma membrane are a key regulator of DRM dynamics at the plasma membrane. Importantly, pathophysiological consequences of β1 integrins-dependent DRM stabilization at the plasma membrane have been poorly addressed so far. Here, using an established osteoblastic model for S. aureus internalization, we extended these findings with a more clinical perspective. Of importance, we also discovered the role of the αvβ3/5 integrin as a “backup” cell receptor for S. aureus invasion in β1-integrin and Cav1-deficient osteoblasts, suggesting the existence of another invasion mechanism (Fig. 4b). It is well recognized that S. aureus main internalization pathway is dependent on β1 integrins via its interaction with fibronectin. Moreover, when β1 integrins are deleted, it cannot be compensated by other fibronectin integrin receptors such as αvβ3 and/or αvβ5, although being expressed by osteoblasts. Surprisingly, deletion of both β1 integrins and Cav1 restored bacterial internalization, challenging the current concept. Indeed, one of the main observations from this work was to identify β1 integrin being required for DRM localization/stabilization at the plasma membrane as an essential regulator of S. aureus cell invasion. The in vivo interaction between S. aureus and bone tissue via the α-hemolysin (Hla) S. aureus virulence factor induced an increased Cav1 expression and a Cav1-induced DRM recruitment at the plasma membrane53. On the other hand, it was also described that a decreased Cav1 expression reduced DRM concentrations at the plasma membrane, which may, based on the observations from the literature, have a negative impact on S. aureus internalization54. However, our results suggest the opposite, where the absence of Cav1 rescued or did not decrease S. aureus internalization. Corroborating our results and Hoffman’s observations in fibroblasts42, Hla overexpression, which is responsible for higher Cav1 and DRM concentrations at the plasma membrane, decreased fibronectin-mediated S. aureus internalization by A549 lung epithelial cells55. As DRMs are cholesterol-enriched membrane structures, Hoffmann’s theory stating that the absence of Cav1 can increase mobility of membrane microdomain-associated proteins and facilitate S. aureus internalization seems to be more in accordance with our results42. It is however important to note that our study is restricted to an in vitro osteoblast internalization model. The absence of other bone tissue components like osteoclasts, osteocytes, the extracellular mineralized matrix and the mechanical forces applied to the tissue prevents us from concluding with certainty that our observations will remain the same in vivo. Thus, it is possible that S. aureus interactions with bone tissue in vivo and in the in vitro model of this study are different. Of note, the discrepancies observed between our results and the literature mainly concern in vivo studies, where opposite conclusions regarding the implication of Cav1 and DRM in the internalization process of S. aureus have been made. On the other hand, observations by Hoffman et al.42. or Liang and Ji55 that are in accordance with our results were made using an in vitro model. Finally, the genetically modified osteoblastic cell lines used in our study do not represent the cell population existing within living bone tissue. In addition, because of their altered surface protein expression profile and their differences in shape that may indicate different cytoskeleton arrangements, likely due to β1 integrin deficiency, they may also interact differently with S. aureus compared with a real clinical setting. Consequently, this study only gives a first insight into the existence of an accessory S. aureus internalization mechanism in vitro. This suggests that the existence of this alternative αvβ3/5-mediated internalization pathway in vivo needs to be investigated to determine its relevance as a potential therapeutic target. Of note, our exploration of the internalization mechanism of S. aureus in OBβ1+/+ cells and in OBβ1−/−Cav1KO mostly relies on chemical inhibition of specific intracellular targets such as Src, Rac1 and PAK1. Therefore, while our results effectively show that chemical inhibition of these intracellular effectors decreases S. aureus internalization in both cell lines, further experiments with mutant cell lines that would support our observations are required to state with more confidence on their role in the internalization process. A few other studies have tried to better decipher the internalization mechanisms by identification of accessory receptors like the major staphylococcal autolysin (Atl), the heat shock cognate protein (Hsc70) or the human heat shock protein Hsp90 as host cell receptor31,56 Regarding Hsc70, it colocalizes with fibronectin and promotes S. aureus internalization, suggesting that this latter acts as a bridge between Hcs70 and α5β1 integrin57. However, this pathway appears more likely to be an accessory mechanism to the canonical α5β1-dependent route described here. Finally, Jang et al. also observed S. aureus internalization in HaCaT cells via the bacterial ESAT-6-like protein EsxB58. Although these studies do not have a direct clinical impact to prevent or treat S. aureus infections, they pave the way to a new non-antibiotic approach to S. aureus infection treatment, by highlighting new host cell therapeutic targets. Indeed, because of S. aureus high propension to become resistant to current antimicrobial strategies, it would be relevant to directly focus on host cell targets instead of the bacterium59. Also, by exploring drug repurposing, time and money could be saved by using already available molecules that can act on newly discovered therapeutic targets60,61. This could be an easy-to-implement, faster and safer alternative to new antimicrobial development in the threatening context of S. aureus antibiotic multiresistance62. This approach has already been reviewed by Evans and McDowell, where statins were used as prophylactic agents and adjuvant therapy against intracellular S. aureus in different clinical studies59. Statins have shown to reduce the risk of contracting S. aureus infections and improve survival rate to infections by disturbing the integrity of the host cell membrane. The comprehension of statins’ mechanism of action in the internalization pathway led to the development of a more specific molecule with similar performance and less adverse effects than statins in the context of S. aureus infections. In summary, in absence of β1 integrins, but also upon recovery of DRMs at the plasma membrane, S. aureus internalization can be mediated by alternative fibronectin receptors such as αvβ3/5, showing that β1 integrin is not an absolute receptor for S. aureus. Of course, we do not underestimate the functional role for β1 integrins as an important cell surface receptor, but our work with the use of genetically modified cells (deficient in β1 integrins, Cav1 and/or both) has highlighted a double role of β1 integrins in S. aureus internalization process. These new findings pave the way for alternative therapeutic strategy that would preferably target the recycling of DRMs rather than β1 integrins that are key molecules involved in many important cell functions. Electronic supplementary material Below is the link to the electronic supplementary material. Supplementary Material 1 Acknowledgements We acknowledge Allison Faure for her technical assistance. Author contributions L.P.T., W.M. and A.C. performed the experiments. L.P.T., W.M., S.T.A., A.D. and J.J. performed data analysis. D.B. and F.L. obtained the FINOVI funding. J.J. obtained the SENS funding. L.P.T., W.M. and J.J. wrote the manuscript. All authors reviewed the manuscript. Funding This research was funded by AO n°11 from Fondation Innovations en Infectiologie (FINOVI) (DB and JJ) and Université Claude Bernard Lyon 1 SENS 2024 (JJ). Data availability All data generated or analyzed during this study are included in this published article (and its Supplementary Information file). Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Léo-Paul Tricou and William Mouton contributed equally to this work. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement All data generated or analyzed during this study are included in this published article (and its Supplementary Information file).